Mergers often lead to positive market sentiment regarding the future prospects of the involved companies. For Kintara Therapeutics, entering into a merger agreement with TuHURA Biosciences is likely seen as a strategic move to enhance its business operations and market position, thus driving investor optimism and causing its stock price to rise in the short term.